3′-Carbamoylbiphenyl-3-yl cyclohexylcarbamate

3′-(aminocarbonyl)-1,1′-biphenyl-3-yl cyclohexylcarbamate

3′-Carbamoyl-3-biphenylyl cyclohexylcarbamate

3′-Carbamoyl-3-biphenylyl-cyclohexylcarbamat

3′-Carbamoyl-[1,1′-biphenyl]-3-yl cyclohexylcarbamate

3′-carbamoyl-[1,1′-biphenyl]-3-yl N-cyclohexylcarbamate

3′-Carbamoylbiphenyl-3-yl cyclohexylcarbamate

546141-08-6

Carbamic acid, N-cyclohexyl-, 3′-(aminocarbonyl)[1,1′-biphenyl]-3-yl ester

cyclohexyl carbamic acid 3′-carbamoylbiphenyl-3-yl ester

Cyclohexyl-carbamic acid 3′-carbamoyl-biphenyl-3-yl ester

Cyclohexylcarbamate de 3′-carbamoyl-3-biphénylyle

MFCD05863934

PX47LB88FO

(3′-(aminocarbonyl)[1,1′-biphenyl]-3-yl)-cyclohexylcarbamate

(3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)cyclohexylcarbamate

-carbamoyl-biphenyl-3-yl Ester, 3ʹ

-Carbamoyl-biphenyl-3-yl-cyclohexylcarbamate

2-Phenyl-1,3-thiazole-5-carbaldehyde

2-Phenylthiazole-5-carbaldehyde

3-(3-carbamoylphenyl)phenyl N-cyclohexylcarbamate

3-[3-(N-cyclohexylcarbamoyloxy)phenyl]benzamide

3-carbamoylbiphenyl-3-ylcyclohexylcarbamate

3′-(aminocarbonyl)-[1,1′-biphenyl]-3-yl cyclohexylcarbamate

3′-carbamoylbiphenyl-3-ylcyclohexylcarbamate

3′carbamoylbiphenyl-3-yl cyclohexylcarbamate

5-hydroxytryptamine receptor 1A

5-hydroxytryptamine receptor 1B

5-hydroxytryptamine receptor 1D

5-hydroxytryptamine receptor 1E

5-hydroxytryptamine receptor 2A

5-hydroxytryptamine receptor 2C

5-hydroxytryptamine receptor 3A

5-hydroxytryptamine receptor 6

5-hydroxytryptamine receptor 7

5HT1A_HUMAN

5HT1B_HUMAN

5HT1D_HUMAN

5HT1E_HUMAN

5HT2A_HUMAN

5HT2C_RAT

5HT3A_HUMAN

5HT6R_HUMAN

5HT7R_HUMAN

[3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate

A0A090N8Q0_HUMAN

ACHA2_HUMAN

ACHA3_HUMAN

ACHA4_HUMAN

ACM1_HUMAN

ACM2_HUMAN

ACM3_HUMAN

ACM4_HUMAN

ACM5_HUMAN

ADA1A_HUMAN

ADA1B_HUMAN

ADA2A_HUMAN

ADA2B_HUMAN

ADA2C_HUMAN

ADRB1_RAT

ADRB2_RAT

AP-2 complex subunit sigma

AP2S1_RAT

ATP-dependent translocase ABCB1

Cannabinoid receptor 1

Cannabinoid receptor 2

Carbamic acid, cyclohexyl-, 3′-(aminocarbonyl)[1,1′-biphenyl]-3-yl ester

CNR1_RAT

CNR2_HUMAN

Cyclohexyl-carbamic acid 3″-carbamoyl-biphenyl-3-yl ester

Cyclohexylcarbamic acid 3′-(Aminocarbonyl)-[1,1′-biphenyl]-3- yl ester

D(1A) dopamine receptor

D(1B) dopamine receptor

D(2) dopamine receptor

D(3) dopamine receptor

D(4) dopamine receptor

DRD1_HUMAN

DRD2_HUMAN

DRD3_RAT

DRD4_HUMAN

DRD5_HUMAN

FAAH Inhibitor II

FAAH Inhibitor II, URB-597, URB 597, KDS-4103

FAAH1_HUMAN

FAAH1_MOUSE

FAAH1_RAT

FAAHInhibitorII

Fatty-acid amide hydrolase 1

Fatty-acid amide hydrolase 1 [30-579]

Histamine H1 receptor

Histamine H2 receptor

HRH1_HUMAN

HRH2_HUMAN

KCNH2_HUMAN

MDR1_HUMAN

Muscarinic acetylcholine receptor M1

Muscarinic acetylcholine receptor M2

Muscarinic acetylcholine receptor M3

Muscarinic acetylcholine receptor M4

Muscarinic acetylcholine receptor M5

n-cyclohexylcarbamic acid 3′-(aminocarbonyl)[1,1′-biphenyl]-3-yl ester

N-cyclohexylcarbamic acid [3-(3-carbamoylphenyl)phenyl] ester

OPRK_HUMAN

OPRM_HUMAN

SC6A2_HUMAN

SC6A3_HUMAN

SGMR1_RAT

Sodium-dependent dopamine transporter

URB597 (KDS-4103)

URB597, Cyclohexylcarbamic acid-3ʹ

URB597,URB-597,KDS4103,KDS-4103

URB597; KDS-4103;URB 597; KDS 4103; KDS4103

α-1A adrenergic receptor

α-1B adrenergic receptor

α-2A adrenergic receptor

α-2B adrenergic receptor

α-2C adrenergic receptor

β-1 adrenergic receptor

β-2 adrenergic receptor

κ-type opioid receptor

μ-type opioid receptor